Comparison of the effect of edoxaban, a direct factor Xa inhibitor, with a direct thrombin inhibitor, melagatran, and heparin on intracerebral hemorrhage induced by collagenase in rats
- 1 April 2014
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 133 (4), 622-628
- https://doi.org/10.1016/j.thromres.2013.07.015
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Anticoagulation With the Oral Direct Thrombin Inhibitor Dabigatran Does Not Enlarge Hematoma Volume in Experimental Intracerebral HemorrhageCirculation, 2011
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)American Heart Journal, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profilesJournal of Thrombosis and Haemostasis, 2008
- Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular DiseaseStroke, 2008
- Prohemorrhagic and Bleeding Time Activities of Recombinant Tissue Plasminogen Activator, Heparin, Aspirin, and a Glycoprotein IIb/IIIa AntagonistJournal of Neurotrauma, 2005
- Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic StrokeStroke, 2002
- THE RELIABILITY OF THROMBOTIC TENDENCY MEASURED BY INTRAVASCULAR WIRES IN THE RATThrombosis Research, 1997
- Collagenase-induced intracerebral hemorrhage in rats.Stroke, 1990
- Thrombin Interactions with Platelet Membrane ProteinsaAnnals of the New York Academy of Sciences, 1986